The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…Left, representative traces of responses stimulated with a 20 ms interpulse interval. Scale bar 5 mV, 40 ms. …”

Quantitation of the decrease in viability of schistosomula caused by GSK343 treatment at different concentrations and incubation times. by Adriana S. A. Pereira (5900249)

Recovery of decreased Hb level after DCV/ASV treatment Mean values and SDs of the Hb levels at each time point are indicated. by Nobuyuki Matsumoto (239090)

Subjects:

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…<p>(A) RFF is decreased by alterations in heart rate. …”

BCG-AS−Ndk has decreased intracellular survival due to increased phagolysosome fusion. by Jim Sun (367834)

Exposure to EtBr decreases mtRNA in rat striatal co-cultures, purified neuronal cultures, and astrocytes. by Emily Booth Warren (4276333)

“…Error bars reflect delta-method propagated +/-SEM, with level of significance determined following Dunn’s post-hoc test. 2D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref005" target="_blank">5</a>] = 5ng/ml EtBr for 2 days, 4D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref005" target="_blank">5</a>] = 5ng/ml EtBr for 4 days, 2D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref050" target="_blank">50</a>] = 50ng/ml EtBr for 2 days, 4D[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0190456#pone.0190456.ref050" target="_blank">50</a>] = 50ng/ml EtBr for 4 days. …”

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Treatment with anti-JAM-C antibody decreases the severity of antigen-induced arthritis by Gaby Palmer (636)

“…Results shown represent the mean ± SEM for anti-JAM-C antibody-treated (= 5 on day 4, = 6 on day 8, black columns) and isotype-matched control antibody-treated (= 5 at both time points, open columns) mice. …”

Obestatin promotes cell survival and decreases serum starvation-induced apoptosis at stage 5. by lessandra Baragli (417177)

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

Mutation of four arginine residues in P34 leads to a decrease in binding between P34 and L5. by Anyango D. Kamina (4034165)

EGCG treatment decreases TTR deposition and associated biomarkers in the gastrointestinal tract of old hTTR V30M mice. by Nelson Ferreira (188837)

csBAP31-positive cells show decreased survival. by Se-Ri Seo (4597801)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Reduced mitochondrial function decreases neuronal PCr/Cr ratio, and decreases glial tCr. by Emily Booth Warren (4276333)

Chemokines, with the exception of CXCL1 and MCP-1, decrease acutely following 5 Gy IR. by Jordan A. Gunning (18143970)

Subjects:

sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

“…When analyzed separately based upon treatment, the decrease in sC5b-9 levels was due to a decrease in patients treated with mycophenolate mofetil (P < 0.001 by linear regression; n = 12 for all time-points). …”

Taste bud cell populations are decreased after <i>Sox2</i> deletion in epithelial stem/progenitor cells. by Makoto Ohmoto (3065106)

PB + PER exposure decreased SYP staining in the hippocampi and cerebral cortices of exposed mice. by Zuchra Zakirova (431614)